Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_assertion type Assertion NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_head.
- NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_assertion wasGeneratedBy ECO_0000203 NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_provenance.
- NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_assertion wasDerivedFrom befree-20150227 NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_provenance.
- NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_assertion SIO_000772 21527514 NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_provenance.
- NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_assertion evidence source_evidence_literature NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_provenance.
- NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_assertion description "[RSK2 may thus represent an alternative therapeutic target in the treatment of FLT3-ITD-positive leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675561.RAiH41zLX-OjbbglqLS6Aod7Z1qak6rL6fiBwspVzFqCM130_provenance.